Clinical trial AL-TNBC-01 - TENACITY
A Phase 2, Multicenter, Open-label, Single arm Study of AL101 Monotherapy in Patients with Notch Activated Triple Negative Breast Cancer
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Ayala Pharmaceuticals, Inc. |
| EudraCT Identifier | 2020-001979-33 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04461600 |
| Last update |